Sometimes drug treatments for early breast cancer are given before breast cancer surgery. This is called neoadjuvant therapy.
If you have neoadjuvant therapy, it means your treatment may start with chemotherapy, targeted therapy or hormone-blocking therapy, usually given for several months before surgery.
Some treatments may continue after surgery.
There are some benefits in having neoadjuvant therapy, but it is not for everyone. You may want to consider your options carefully. Talk to your doctor about the pros and cons of neoadjuvant therapy. You may find the Neoadjuvant Patient Decision Aid from Breast Cancer Trials helpful in discussions with your treating doctor.
Neoadjuvant therapy may be recommended:
Conference for people affected by metastatic breast cancer
People often use complementary therapies to manage side effects and to improve wellbeing but discuss these with your treatment team first
Chemotherapy through a drip or in a tablet is common to control or slow metastatic breast cancer, relieve symptoms and improve quality of life
Hormone-blocking therapies may be used in treatment. Understand which type is right for you, how it works, and possible side effects
Treatment types vary, depending on the type of metastatic breast cancer and where it has spread. Understand the options
If you choose alternative therapies that are unproven, instead of conventional breast cancer treatment, discuss this with your doctor
About 70 to 80 per cent of breast cancers are hormone receptor-positive. Find out about treatment and support